image
Technology - Software - Application - NASDAQ - US
$ 166.97
0.24 %
$ 20 B
Market Cap
45.87
P/E
1. INTRINSIC VALUE

This DCF valuation model was last updated on Jun, 21, 2025.

The intrinsic value of one PTC stock under the worst case scenario is HIDDEN Compared to the current market price of 167 USD, PTC Inc. is HIDDEN

This DCF valuation model was last updated on Jun, 21, 2025.

The intrinsic value of one PTC stock under the base case scenario is HIDDEN Compared to the current market price of 167 USD, PTC Inc. is HIDDEN

This DCF valuation model was last updated on Jun, 21, 2025.

The intrinsic value of one PTC stock under the best case scenario is HIDDEN Compared to the current market price of 167 USD, PTC Inc. is HIDDEN

2. FUNDAMENTAL ANALYSIS

Price Chart PTC

image
$200.0$200.0$190.0$190.0$180.0$180.0$170.0$170.0$160.0$160.0$150.0$150.0$140.0$140.0$130.0$130.0Jan '25Jan '2515 Jan15 JanFeb '25Feb '2515 Feb15 FebMar '25Mar '2515 Mar15 MarApr '25Apr '2515 Apr15 AprMay '25May '2515 May15 MayJun '25Jun '2515 Jun15 Jun
FINANCIALS
2.3 B REVENUE
9.60%
588 M OPERATING INCOME
28.27%
376 M NET INCOME
53.27%
750 M OPERATING CASH FLOW
22.77%
-125 M INVESTING CASH FLOW
85.46%
-651 M FINANCING CASH FLOW
-249.60%
636 M REVENUE
12.61%
223 M OPERATING INCOME
93.44%
163 M NET INCOME
97.79%
281 M OPERATING CASH FLOW
17.98%
-18.9 M INVESTING CASH FLOW
-73.83%
-227 M FINANCING CASH FLOW
30.08%
Balance Sheet PTC Inc.
image
Current Assets 1.3 B
Cash & Short-Term Investments 266 M
Receivables 862 M
Other Current Assets 171 M
Non-Current Assets 5.08 B
Long-Term Investments 10 K
PP&E 209 M
Other Non-Current Assets 4.88 B
4.16 %13.50 %3.27 %76.39 %Total Assets$6.4b
Current Liabilities 1.67 B
Accounts Payable 24.2 M
Short-Term Debt 546 M
Other Current Liabilities 1.1 B
Non-Current Liabilities 1.5 B
Long-Term Debt 1.38 B
Other Non-Current Liabilities 117 M
17.22 %34.63 %43.69 %3.70 %Total Liabilities$3.2b
EFFICIENCY
Earnings Waterfall PTC Inc.
image
Revenue 2.3 B
Cost Of Revenue 445 M
Gross Profit 1.85 B
Operating Expenses 1.22 B
Operating Income 588 M
Other Expenses 212 M
Net Income 376 M
3b3b2b2b2b2b1b1b500m500m002b(445m)2b(1b)588m(212m)376mRevenueRevenueCost Of RevenueCost Of RevenueGross ProfitGross ProfitOperating ExpensesOperating ExpensesOperating IncomeOperating IncomeOther ExpensesOther ExpensesNet IncomeNet Income
RATIOS
80.65% GROSS MARGIN
80.65%
25.58% OPERATING MARGIN
25.58%
16.37% NET MARGIN
16.37%
11.71% ROE
11.71%
5.90% ROA
5.90%
8.97% ROIC
8.97%
FREE CASH FLOW ANALYSIS
Free Cash Flow Analysis PTC Inc.
image
800m800m700m700m600m600m500m500m400m400m300m300m200m200m100m100m0020162016201720172018201820192019202020202021202120222022202320232024202420252025
Net Income 376 M
Depreciation & Amortization 141 M
Capital Expenditures -14.4 M
Stock-Based Compensation 223 M
Change in Working Capital 49.4 M
Others 24.7 M
Free Cash Flow 736 M
3. WALL STREET ANALYSTS ESTIMATES
Wall Street Analysts Price Targets PTC Inc.
image
Wall Street analysts predict an average 1-year price target for PTC of $201 , with forecasts ranging from a low of $175 to a high of $228 .
PTC Lowest Price Target Wall Street Target
175 USD 4.81%
PTC Average Price Target Wall Street Target
201 USD 20.16%
PTC Highest Price Target Wall Street Target
228 USD 36.55%
Price
Max Price Target
Min Price Target
Average Price Target
230230220220210210200200190190180180170170160160150150140140130130Aug '24Aug '24Oct '24Oct '24Nov '24Nov '2420252025Feb '25Feb '25Apr '25Apr '25Jun '25Jun '25Jul '25Jul '25Aug '25Aug '25Oct '25Oct '25Nov '25Nov '2520262026Feb '26Feb '26Apr '26Apr '26Jun '26Jun '26
4. DIVIDEND ANALYSIS
5. COMPETITION
slide 2 of 11
6. Ownership
Insider Ownership PTC Inc.
image
Sold
0-3 MONTHS
324 K USD 2
3-6 MONTHS
323 K USD 2
6-9 MONTHS
5.6 M USD 4
9-12 MONTHS
3.22 M USD 5
Bought
0 USD 0
0-3 MONTHS
0 USD 0
3-6 MONTHS
0 USD 0
6-9 MONTHS
0 USD 0
9-12 MONTHS
7. News
PTC Therapeutics Reports Inducement Grants Under Nasdaq Listing Rule 5635(c)(4) WARREN, N.J. , June 19, 2025 /PRNewswire/ -- PTC Therapeutics, Inc. (NASDAQ: PTCT) today announced that on June 16, 2025, the company approved non-statutory stock options to purchase an aggregate of 12,725 shares of its common stock and 27,790 restricted stock units ("RSUs"), each representing the right to receive one share of its common stock upon vesting, to 34 new employees. prnewswire.com - 6 days ago
INVESTOR ALERT: Pomerantz Law Firm Investigates Claims On Behalf of Investors of PTC Therapeutics, Inc. - PTCT NEW YORK, June 18, 2025 (GLOBE NEWSWIRE) -- Pomerantz LLP is investigating claims on behalf of investors of PTC Therapeutics, Inc. (“PTC” or the “Company”) (NASDAQ: PTCT). Such investors are advised to contact Danielle Peyton at newaction@pomlaw.com  or 646-581-9980, ext. 7980. globenewswire.com - 1 week ago
INVESTOR ALERT: Pomerantz Law Firm Investigates Claims On Behalf of Investors of PTC Therapeutics, Inc. - PTCT NEW YORK , June 17, 2025 /PRNewswire/ -- Pomerantz LLP is investigating claims on behalf of investors of PTC Therapeutics, Inc. ("PTC" or the "Company") (NASDAQ: PTCT).  Such investors are advised to contact Danielle Peyton at newaction@pomlaw.com or 646-581-9980, ext. prnewswire.com - 1 week ago
INVESTOR ALERT: Pomerantz Law Firm Investigates Claims On Behalf of Investors of PTC Therapeutics, Inc. - PTCT NEW YORK CITY, NY / ACCESS Newswire / June 16, 2025 / Pomerantz LLP is investigating claims on behalf of investors of PTC Therapeutics, Inc. ("PTC" or the "Company") (NASDAQ:PTCT). Such investors are advised to contact Danielle Peyton at newaction@pomlaw.com or 646-581-9980, ext. accessnewswire.com - 1 week ago
PTC Brings Cloud-Native Model-Based Definition to Onshape PTC debuts the first cloud-native MBD in Onshape, aiming to cut 2D drawing reliance and streamline product development. zacks.com - 1 week ago
INVESTOR ALERT: Pomerantz Law Firm Investigates Claims On Behalf of Investors of PTC Therapeutics, Inc. - PTCT NEW YORK CITY, NY / ACCESS Newswire / June 13, 2025 / Pomerantz LLP is investigating claims on behalf of investors of PTC Therapeutics, Inc. ("PTC" or the "Company") (NASDAQ:PTCT). Such investors are advised to contact Danielle Peyton at newaction@pomlaw.com or 646-581-9980, ext. accessnewswire.com - 1 week ago
PTC: Margin Strength Meets Valuation Reset PTC's diversified software suite and high-margin recurring revenue model drive solid fundamentals, despite capability competition from Autodesk and Dassault. Operating margins are expanding, now at ~35%, and PTC trades at a valuation discount versus peers, offering attractive upside if ARR growth reaccelerates. Strategic SaaS pivots and targeted R&D deliver superior margin efficiency and innovation, positioning PTC well for long-term cloud-native trends in industrials. seekingalpha.com - 1 week ago
INVESTOR ALERT: Pomerantz Law Firm Investigates Claims On Behalf of Investors of PTC Therapeutics, Inc. - PTCT NEW YORK , June 12, 2025 /PRNewswire/ -- Pomerantz LLP is investigating claims on behalf of investors of PTC Therapeutics, Inc. ("PTC" or the "Company") (NASDAQ: PTCT). Such investors are advised to contact Danielle Peyton at newaction@pomlaw.com or 646-581-9980, ext. prnewswire.com - 2 weeks ago
PTC Unveils Onshape's Next-Generation Model-Based Definition Capabilities with Aura Aero at Paris Air Show Industry's first MBD offering delivering complete digital definition of a product within a cloud-native CAD and PDM solution Cloud-native MBD in Onshape enables better collaboration between engineering, supply chain, and manufacturing teams PTC and Aura Aero, a leader in sustainable aviation, will preview cloud-native MBD in Onshape at Paris Air Show BOSTON , June 12, 2025 /PRNewswire/ -- PTC (NASDAQ: PTC) today announced model-based definition (MBD) capabilities within its Onshape® computer-aided design (CAD) and product data management (PDM) platform. MBD in Onshape is the first MBD offering within a cloud-native CAD and PDM solution and enables engineering teams to create a complete digital definition of a product by embedding all common product manufacturing information (PMI) directly into the 3D CAD model, including dimensions, tolerances, annotations, surface finishes, material specifications, and more. prnewswire.com - 2 weeks ago
PTC Revamps Go-To-Market Approach But Client Decisions Slow PTC recently delivered good quarterly results, beating revenue and earnings estimates, but customer caution may slow growth in the second half of fiscal 2025. Recent sales team restructuring and a focus on vertical markets are promising, yet macroeconomic pressures are causing management to guide conservatively. PTC's capital allocation has been efficient enough, with significant stock buybacks offsetting high stock-based compensation, but ARR growth guidance has been trimmed to 9%. seekingalpha.com - 2 weeks ago
INVESTOR ALERT: Pomerantz Law Firm Investigates Claims On Behalf of Investors of PTC Therapeutics, Inc. - PTCT NEW YORK CITY, NY / ACCESS Newswire / June 11, 2025 / Pomerantz LLP is investigating claims on behalf of investors of PTC Therapeutics, Inc. ("PTC" or the "Company") (NASDAQ:PTCT). Such investors are advised to contact Danielle Peyton at newaction@pomlaw.com or 646-581-9980, ext. accessnewswire.com - 2 weeks ago
INVESTOR ALERT: Pomerantz Law Firm Investigates Claims On Behalf of Investors of PTC Therapeutics, Inc. - PTCT NEW YORK CITY, NY / ACCESS Newswire / June 9, 2025 / Pomerantz LLP is investigating claims on behalf of investors of PTC Therapeutics, Inc. ("PTC" or the "Company") (NASDAQ:PTCT). Such investors are advised to contact Danielle Peyton at newaction@pomlaw.com or 646-581-9980, ext. accessnewswire.com - 2 weeks ago
8. Profile Summary

PTC Inc. PTC

image
COUNTRY US
INDUSTRY Software - Application
MARKET CAP $ 20 B
Dividend Yield 0.00%
Description PTC Inc. operates as software and services company in the Americas, Europe, and the Asia Pacific. The company operates in two segments, Software Products and Professional Services. It offers ThingWorx platform, which offers a set of capabilities that enable enterprises to digitally transform every aspect of their business with innovative solutions that are simple to create, easy to implement, scalable to meet future needs, and designed to enable customers to accelerate time to value; and Vuforia, which enables the visualization of digital information in a physical context and the creation of AR. The company also provides Onshape, a software-as-a-service product development platform unites computer-aided design with data management, collaboration tools, and real-time analytics; Arena, a PLM solution enables product teams to collaborate virtually anytime and anywhere; Creo, a 3D CAD technology enables the digital design, testing, and modification of product models; and Windchill, a product lifecycle management software. In addition, it offers Integrity, an application lifecycle management solution; Servigistics, service parts management solution; and consulting, implementation, training, cloud, and license and support services. The company was formerly known as Parametric Technology Corporation and changed its name to PTC Inc. in January 2013. PTC Inc. was incorporated in 1985 and is headquartered in Boston, Massachusetts.
Contact 121 Seaport Boulevard, Boston, MA, 02210 https://www.ptc.com
IPO Date Dec. 8, 1989
Employees 7512
Officers Mr. Kristian P. Talvitie Executive Vice President & Chief Financial Officer Mr. Aaron C. Von Staats Esq. Executive Vice President, General Counsel & Corporate Secretary Ms. Lisa Reilly Executive Vice President & Chief People Officer Ms. Catherine A. Kniker EVice President, Chief Marketing & Sustainability Officer Ms. Alice Christenson Chief Accounting Officer Mr. Matthew Shimao Senior Vice President of Investor Relations Mr. Kevin P. Wrenn Chief Product Officer Catherine Gorecki Senior Vice President of Corporate & Securities Counsel and Assistant Secretary Mr. Eric Snow Senior Vice President of Corporate Marketing Mr. Neil Barua President, Chief Executive Officer & Director